Attached files
file | filename |
---|---|
EX-99.1 - SERACARE LIFE SCIENCES INC | v204166_ex99-1.htm |
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event
Reported): November 29, 2010
SeraCare Life Sciences,
Inc.
(Exact name of registrant as
specified in its charter)
Delaware
|
1-34105
|
33-0056054
|
||
(State or other jurisdiction
|
(Commission
|
(I.R.S. Employer
|
||
of incorporation)
|
File Number)
|
Identification No.)
|
||
|
||||
37 Birch Street, Milford, Massachusetts
|
01757
|
|||
(Address of principal executive offices)
|
|
|
(Zip Code)
|
Registrant's telephone number,
including area code: (508) 244-6400
Not
Applicable
Former name or former
address, if changed since last report
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02
|
Results
of Operations and Financial
Condition.
|
On
December 1, 2010, we issued a press release announcing our financial results for
the quarter and fiscal year ended September 30, 2010. A copy of
the press release is attached hereto as exhibit 99.1 and incorporated by
reference herein.
The
information in this Item 2.02 and the press release attached hereto shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or the Exchange Act, or otherwise subject to the liabilities
of that section, nor shall they be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act,
regardless of any general incorporation language in such filing.
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
November 29, 2010, William J. Smutny agreed to step down from his position as
Vice President, Sales and Marketing. It is expected that Mr. Smutny’s
employment will end on or before December 31, 2010. The terms of his
severance package have not been finalized.
Item
9.01
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits
|
Exhibit
No.
|
Description
|
99.1
|
Press
Release issued by SeraCare Life Sciences, Inc. dated December 1,
2010
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly
authorized.
SeraCare Life Sciences, Inc.
|
||||
|
||||
December 1, 2010
|
By:
|
/s/ Gregory A. Gould
|
||
Name: Gregory A. Gould
|
||||
Title: Chief Financial Officer, Treasurer and Secretary
|
Exhibit Index
Exhibit No.
|
Description
|
|
99.1
|
Press
Release issued by SeraCare Life Sciences, Inc., dated December 1,
2010.
|